Francisco Rodriguez-Jerez
Overview
Explore the profile of Francisco Rodriguez-Jerez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguirre-Alastuey M, Suarez-Diaz S, Rodriguez-Jerez F, Coto-Hernandez R, Caminal-Montero L
Lupus
. 2020 Oct;
30(1):172-174.
PMID: 33092468
No abstract available.
2.
Masa J, Utrabo I, de Terreros J, Aburto M, Esteban C, Prats E, et al.
BMC Pulm Med
. 2016 Jul;
16(1):97.
PMID: 27387544
Background: Severe acidosis can cause noninvasive ventilation (NIV) failure in chronic obstructive pulmonary disease (COPD) patients with acute hypercapnic respiratory failure (AHRF). NIV is therefore contraindicated outside of intensive care...
3.
Morell F, Cruz M, Gomez F, Rodriguez-Jerez F, Xaubet A, Munoz X
Scand J Work Environ Health
. 2011 Feb;
37(4):349-56.
PMID: 21327319
Objective: Hypersensitivity pneumonitis (HP) comprises a large group of diseases that occur secondary to inhalation of a variety of antigens. This report describes a little-known cause of HP, previously unreported...
4.
Haro-Estarriol M, Sabater-Talaverano G, Rodriguez-Jerez F, Obrador-Lagares A, Genis-Batlle D, Sendra-Salillas S
Arch Bronconeumol
. 2009 Feb;
45(2):100-2.
PMID: 19232272
Cabergoline is a synthetic dopamine agonist used to treat Parkinson disease. The drug occasionally induces pleuropulmonary adverse effects, which manifest as pleural thickening or effusion, interstitial pneumonitis, pulmonary infiltrates, or...